Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material (Plastic, Glass), By End Use (Hospitals & Clinics, Blood Collection Centers, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F

Market Overview

Global Syringes Market was valued at USD 15.02 Billion in 2024 and is expected to reach USD 20.69 Billion by 2030 with a CAGR of 5.68%. Syringes, essential medical devices used for administering medications and vaccines remain critical to modern healthcare delivery, spanning applications in hospitals, clinics, ambulatory centers, and home care settings. One of the primary growth drivers is the rising burden of chronic and infectious diseases, including diabetes, cardiovascular conditions, and respiratory illnesses, which require frequent or long-term administration of injectable medications.

Despite robust growth prospects, the market faces challenges such as environmental concerns associated with plastic waste, supply chain disruptions, and pricing pressures, especially in low- and middle-income countries. Moreover, the availability of counterfeit or substandard products in certain regions poses risks to patient safety and market credibility.

Key Market Drivers

Growth in Healthcare Industry

The global healthcare industry generates annual sales exceeding USD 4 trillion. Among its most significant and profitable segments are pharmaceuticals and biotechnology, contributing nearly USD 850 billion, followed by medical technology and diagnostics, which account for over USD 400 billion. The steady growth of the healthcare industry has emerged as a primary driver of the global syringes market, fueled by increasing demand for advanced medical treatments, expanding healthcare infrastructure, and a rising global patient population. As healthcare systems across developed and emerging economies invest in improving access to care and enhancing medical services, the need for efficient, safe, and cost-effective drug delivery mechanisms such as syringes continues to surge.

In 2021, noncommunicable diseases (NCDs) were the leading cause of death globally, responsible for approximately 43 million fatalities representing 75% of all non-pandemic-related deaths. Notably, 18 million of these deaths occurred prematurely, before the age of 70, with 82% taking place in low- and middle-income countries. A key factor contributing to this trend is the escalating prevalence of chronic diseases, including diabetes, cancer, and cardiovascular conditions, which require frequent and precise administration of medications. Syringes, particularly those designed for subcutaneous and intravenous injections, play a crucial role in managing such conditions and have become indispensable tools in routine clinical practice.

Surge in Technological Advancements

The surge in technological advancements has emerged as a key driver of growth in the global syringes market, fundamentally transforming the design, functionality, and application of these essential medical devices. Innovations in safety features, materials, and smart technology are not only improving patient outcomes but are also aligning with the increasing demand for efficient, precise, and sustainable healthcare solutions.

One of the most notable developments is the rise of safety-engineered syringes, such as retractable and auto-disable models, which are designed to minimize the risk of needlestick injuries and prevent reuse. Prefilled syringe smart syringes are increasingly favored over traditional needle-and-vial delivery systems due to their ability to maintain drug sterility, minimize waste from overfilling, enhance needlestick safety, streamline the administration process, and lower the risk of dosing errors. These features have gained widespread acceptance in clinical settings, particularly in vaccination campaigns and chronic disease management, where safety and infection control are paramount.

Download Free Sample Report

Key Market Challenges

Rise in Environmental Concerns

The rise in environmental concerns has emerged as a significant challenge for the global syringes market, particularly in light of the increasing use of disposable medical products. Syringes, especially single-use plastic variants, contribute substantially to medical waste, raising critical sustainability and environmental management issues for healthcare systems worldwide.

One of the primary concerns is the sheer volume of plastic waste generated by syringe usage. With billions of syringes used annually for vaccinations, chronic disease management, and therapeutic injections, the disposal of non-biodegradable materials has become a growing environmental burden. Improper disposal practices particularly in regions with underdeveloped medical waste management infrastructure pose risks to public health and the environment through contamination of landfills, water sources, and ecosystems.

Key Market Trends

Expansion of Home Healthcare and Self-Administration

Particularly, India’s home healthcare sector has witnessed substantial growth, reaching a market size of USD 5.4 billion. Projections indicate that the segment is set to expand to USD 19.9 billion by 2025. With the appropriate strategic support and policy initiatives, the market holds the potential to further grow by an additional USD 5 billion. The expansion of home healthcare and the increasing trend of self-administration have emerged as significant drivers in the global syringes market, reflecting a broader shift toward patient-centric care and decentralized healthcare delivery. As healthcare systems worldwide prioritize cost efficiency, convenience, and improved patient outcomes, the demand for syringes designed for use outside traditional clinical settings has grown considerably.

A rising number of patients with chronic conditions such as diabetes, autoimmune disorders, and hormonal imbalances now manage their treatments at home. This has fueled demand for syringes that support self-injection, including prefilled, safety, and autoinjector-compatible syringes. These devices offer ease of use, minimize the risk of dosing errors, and reduce the likelihood of needle-stick injuries, thereby enhancing patient compliance and treatment effectiveness.

Segmental Insights

Material Insights

Based on Material, Plastic have emerged as the fastest growing segment in the Global Syringes Market in 2024. This is primarily due to its cost-effectiveness, versatility, and adaptability in mass production. Unlike traditional glass syringes, plastic syringes are lightweight, durable, and less prone to breakage, making them highly suitable for a wide range of medical applications, including general drug administration, vaccination programs, and emergency care. One of the key factors driving the growth of plastic syringes is their compatibility with modern manufacturing techniques, such as injection molding, which enables high-volume, low-cost production with consistent quality. This scalability has proven essential during global public health initiatives, such as large-scale immunization drives, where billions of syringes are required within short timeframes.

End Use Insights

Based on End Use, Hospitals & Clinics have emerged as the fastest growing segment in the Global Syringes Market during the forecast period. This is due to the increasing volume of medical procedures and routine treatments that require precise and reliable drug administration. These healthcare settings serve as the primary points of care for vaccinations, intravenous therapies, anesthesia delivery, and chronic disease management all of which depend heavily on the consistent use of syringes. Hospitals and clinics also benefit from centralized procurement processes, enabling them to adopt advanced syringe types, including safety-engineered, auto-disable, and prefilled syringes, which enhance patient and healthcare worker safety.

Download Free Sample Report

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Syringes Market in 2024. This is due to its advanced healthcare infrastructure, high disease burden, and strong regulatory framework that supports innovation and safety in medical devices. The region is characterized by a high adoption rate of advanced injectable therapies, including biologics and vaccines, which has substantially increased the demand for both conventional and prefilled syringes. The United States, in particular, plays a pivotal role in this dominance, being home to many of the world’s leading pharmaceutical companies and syringe manufacturers.

Recent Development

• In January 2025, SCHOTT Pharma, a leading provider of drug containment and delivery solutions, introduced the next generation of its SCHOTT TOPPAC infuse polymer syringes, an advanced system engineered to enhance safety, operational efficiency, and sustainability in healthcare settings. Developed in collaboration with Alliance to Zero partners Schreiner MediPharm and Körber Pharma, the system features a redesigned cap, a functional label, and optimized carton packaging. This innovative solution directly addresses key challenges faced by hospitals, such as excessive medication waste, labor-intensive manual handling, and limited storage capacity, while also advancing patient safety and supporting sustainability across the healthcare value chain.
• In March 2024, Hindustan Syringes and Medical Devices (HMD), a prominent manufacturer of disposable and auto-disable syringes, announced the launch of Dispojekt, an indigenously developed single-use safety syringe designed to significantly minimize the risk of needle stick injuries (NSIs) in clinical settings. NSIs, which occur when healthcare personnel are accidentally pricked by hollow-bore needles contaminated with blood or bodily fluids, pose a serious occupational hazard, potentially leading to the transmission of blood-borne infections such as Hepatitis B, Hepatitis C, and HIV, thereby underscoring the urgent need for safer injection practices.
• In April 2025, following its inaugural virtual presentation at Interphex, Syntegon officially launched its latest filling machine designed for ready-to-use (RTU) nested syringes. The MLD Advanced addresses the growing demand among pharmaceutical manufacturers for high-throughput solutions combined with 100% in-process control (IPC). Leveraging proven automatic bag and tub openers, the system enables aseptic, no-touch transfer of syringes into the filling zone. Additionally, Syntegon’s newly developed Pharma Handling Unit automates syringe denesting without any glass-to-glass contact and seamlessly places the containers into the pitch adjustment station, ensuring both safety and efficiency in the filling process.
• In 2025, Vetter announced the development and forthcoming launch of an enhanced version of its proprietary V-OVS syringe closure system, known as V-OVS next. Building on a legacy of proven market success, V-OVS next is designed to further strengthen the performance and differentiation of sterile injectable products. This next-generation system incorporates a range of innovative technical enhancements, shaped by evolving market demands and valuable insights from customers currently using the original V-OVS solution. Consistent with its predecessor, V-OVS next is engineered to ensure the highest level of product integrity and protection for the injectable contents.

Key Market Players

• Becton, Dickinson, and Company
• Terumo Corporation
• Medtronic plc
• B. Braun Medical Inc.
• Nipro Corporation
• Hindustan Syringes & Medical Devices Ltd.
• Gerresheimer AG
• SCHOTT AG
• CODAN Medizinische Geräte GmbH
• Baxter Healthcare Corporation

Report Scope

In this report, the Global Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Syringes Market, By Material:

o   Plastic

o   Glass

• Syringes Market, By End Use:

o   Hospitals & Clinics

o   Blood Collection Centers

o   Ambulatory Care Centers

o   Others

• Syringes Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Syringes Market.

Available Customizations:

Global Syringes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Syringes Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]